Peak Bio, Inc. Annual Income Tax Expense (Benefit) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Peak Bio, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2021 to 2023.
  • Peak Bio, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Peak Bio, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $0.000.
  • Peak Bio, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Peak Bio, Inc. annual Income Tax Expense (Benefit) for 2022 was -$74K, a 190% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 +$74K Jan 1, 2023 Dec 31, 2023 10-K 2024-08-06
2022 -$74K -$156K -190% Jan 1, 2022 Dec 31, 2022 10-K 2024-08-06
2021 $82.1K Jan 1, 2021 Dec 31, 2021 10-K 2023-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.